TheStreet.com Ratings provides exclusive stock, ETF and mutual fund ratings and commentary based on award-winning, proprietary tools. Its "safety first" approach to investing aims to reduce risk while seeking solid outperformance on a total return basis.The big news for health care is not all on Capitol Hill. Health-care and biotechnology mutual funds have outperformed all other industries, rising an average of 3.9% last month. Funds focused on the sector made the most of investors' interest in drug and hospital stocks. The top-performing health or biotechnology fund, Fidelity Advisor Biotechnology ( FBTAX), gained 8.6%, excluding a sales fee of 5.75% and other expenses. Managed by Rajiv Kaul, the fund increased another 1.5% in the past week.